Armistice Capital’s Telix Pharmaceuticals TLX Stock Holding History
Bought
Maintained
Sold
Other funds holding TLX
Armistice Capital's TLX Position: Q3 2026 in Review
Armistice Capital opened a new position in Telix Pharmaceuticals (TLX) in Q3 2026: 1,670,000 shares worth $18.3M. The stake represents 0.22% of the portfolio and ranks #66 among its holdings.
71 funds tracked by Wall St. Rank hold TLX as of Q3 2026.
- Armistice Capital held 1,670,000 shares of Telix Pharmaceuticals worth $18.3M as of Q3 2026.
- Telix Pharmaceuticals was a new Armistice Capital position in Q3 2026.
- Telix Pharmaceuticals made up 0.22% of Armistice Capital's portfolio in Q3 2026, its #66 holding.
- 71 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.